# Centre Hospitalier Universitaire de Nice: Phase 3 study started recruiting, 170 planned (Erosive Hand Osteoarthritis)

**Score:** 60/100

| Field | Value |
|---|---|
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Sponsor type | Academic and hospital |
| Study | Methotrexate Treatment in Hand Osteoarthritis Refractory to Usual Treatments |
| NCT ID | NCT07501507 |
| Phase | Phase 3 |
| Status | recruiting |
| Conditions | Erosive Hand Osteoarthritis |
| Intervention types | drug |
| Target enrollment | 170 |
| Site countries | France |
| Posted | 2026-03-30 |
| Planned start | 2026-09-23 |
| Event | Started recruiting |
| Event date | 2026-09-23 |
| Last update posted | 2026-09-24 |

## Why this score
- Just started recruiting: sites, recruitment and supply are active.
- Phase 3: multi-site, larger budget.
- 170 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07501507). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.